Apple Awards $10 Million from Advanced Manufacturing Fund to COPAN Diagnostics
07 Maio 2020 - 8:10AM
Business Wire
Apple® today announced it is awarding $10 million from its
Advanced Manufacturing Fund to COPAN Diagnostics, a market leader
in sample collection kits that play a critical role in COVID-19
testing. This funding will allow COPAN Diagnostics to rapidly
accelerate their supply of sample collection kits for hospitals
across the United States, expanding production from several
thousand today to more than one million kits per week by early
July. As part of this effort, Apple will support COPAN Diagnostics’
expansion to a new, larger facility in Southern California, with
advanced equipment that Apple is helping design. This expansion is
expected to create more than 50 new jobs.
“We feel a deep sense of responsibility to do everything we can
to help medical workers, patients, and communities support the
global response to COVID-19,” said Jeff Williams, Apple’s chief
operating officer. “COPAN is one of the world’s most innovative
manufacturers of sample collection kits for COVID-19 testing, and
we’re thrilled to partner with them so they can expand as we work
to address this critical issue for our nation. I couldn’t be
prouder of our teams for bringing all of their energy, passion, and
innovative spirit to supporting the country’s COVID-19
response.”
“We’re excited to forge this new relationship with Apple, whose
teams are already making a huge difference with our efforts to
scale up the production of our sample collection and transport
kits,” said Norman Sharples, CEO of COPAN Diagnostics. “Collection
and transport kits are a critical component in the fight against
COVID-19. At COPAN, we’re excited and grateful for this partnership
with Apple as our strong beliefs of innovation, quality, and
excellence in manufacturing and design are perfectly aligned.
Apple’s operational expertise will help us increase delivery of
important pre-analytical tools for medical professionals across the
country at this critical time.”
Apple is sourcing equipment and materials for COPAN Diagnostics
from companies across the US, including equipment Apple is helping
design from K2 Kinetics, based in York, Pennsylvania, and MWES in
Waukesha, Wisconsin.
COPAN is a global player in the field of specimen collection and
preservation for infectious disease diagnostics. The company’s
sample collection kits have revolutionized the diagnostic industry
and play a critical role in the COVID-19 testing process. The
company’s unique quantitative approach to pre-analytics led them to
invent flocked swabs in 2003, a revolutionary device comprising of
a molded plastic applicator stick that has variable tips coated
with Nylon fibers allowing for quick uptake and complete elution of
the sample. COPAN’s UTM is the leading transport medium for
collection, transport, preservation, and long-term freeze storage
of clinical specimens containing viruses.
Apple’s Support for the Worldwide Response to
COVID-19
Apple has donated tens of millions of dollars toward the global
COVID-19 response, including Global Citizen and America’s Food
Fund. In addition, Apple designed, tested, and distributed almost
10 million face shields and sourced over 30 million face masks for
healthcare professionals in hard-hit areas. Apple also developed a
COVID-19 symptom-checking website and app in partnership with the
CDC, and announced a collaboration with Google to develop COVID-19
contact tracing technology to help governments and health agencies
reduce the spread of the virus, with user privacy and security
central to the design.
Apple’s impact also extends to its range of innovative services.
Apple News® is connecting users with trusted information from
reliable sources with its dedicated COVID-19 section, and Apple has
worked with everyone from Oprah to Lady Gaga to help customers find
information, entertainment, and ways to contribute to charitable
causes through Apple TV®.
Apple in the United States
Apple is on track to reach its commitment of contributing $350
billion to the US economy over a five year period. The company
supports 2.4 million jobs across the US, including 90,000 direct
employees in all 50 states.
Apple has already invested more than $1 billion of its $5
billion Advanced Manufacturing Fund in American companies fostering
innovation and growth in the US manufacturing sector. That includes
$450 million distributed to Corning Incorporated in Harrodsburg,
Kentucky, to support its research and development into
state-of-the-art glass processes, equipment, and materials integral
to the delivery of next-generation consumer devices; $390 million
to Finisar in Sherman, Texas, to increase its R&D spending and
high-volume production of vertical-cavity surface-emitting lasers;
and $10 million allocated to the Elysis aluminum partnership to
bring revolutionary advancements in green aluminum manufacturing to
the commercial market.
Apple revolutionized personal technology with the introduction
of the Macintosh in 1984. Today, Apple leads the world in
innovation with iPhone, iPad, Mac, Apple Watch, and Apple TV.
Apple’s five software platforms — iOS, iPadOS, macOS, watchOS, and
tvOS — provide seamless experiences across all Apple devices and
empower people with breakthrough services including the App Store,
Apple Music, Apple Pay, and iCloud. Apple’s more than 100,000
employees are dedicated to making the best products on earth, and
to leaving the world better than we found it.
NOTE TO EDITORS: For additional information visit Apple Newsroom
(www.apple.com/newsroom), or call Apple’s Media Helpline at (408)
974-2042.
© 2020 Apple Inc. All rights reserved. Apple, the Apple logo,
Apple News, and Apple TV are trademarks of Apple. Other company and
product names may be trademarks of their respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200507005281/en/
Apple Josh Rosenstock, (408) 862-1142 jrosenstock@apple.com
Apple (NASDAQ:AAPL)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Apple (NASDAQ:AAPL)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024